| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.
|
Eur Urol
|
2013
|
3.41
|
|
2
|
Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy.
|
J Clin Oncol
|
2002
|
3.06
|
|
3
|
Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2004
|
2.84
|
|
4
|
Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience.
|
Int J Radiat Oncol Biol Phys
|
2007
|
2.41
|
|
5
|
Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era.
|
J Urol
|
2012
|
2.24
|
|
6
|
Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation.
|
Radiother Oncol
|
2004
|
2.01
|
|
7
|
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.
|
Int J Radiat Oncol Biol Phys
|
2002
|
2.01
|
|
8
|
Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
|
J Thorac Oncol
|
2009
|
1.87
|
|
9
|
Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.71
|
|
10
|
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
|
J Neurosurg
|
2011
|
1.70
|
|
11
|
A retrospective comparison of androgen deprivation (AD) vs. no AD among low-risk and intermediate-risk prostate cancer patients treated with brachytherapy, external beam radiotherapy, or radical prostatectomy.
|
Int J Radiat Oncol Biol Phys
|
2004
|
1.64
|
|
12
|
Modern outcomes of inflammatory breast cancer.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.63
|
|
13
|
Risk for developing myelodysplastic syndromes in prostate cancer patients definitively treated with radiation.
|
J Natl Cancer Inst
|
2014
|
1.56
|
|
14
|
Five year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation.
|
Urology
|
2010
|
1.53
|
|
15
|
Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis.
|
Urology
|
2012
|
1.42
|
|
16
|
Postoperative single-fraction radiation for prevention of heterotopic ossification of the elbow.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.40
|
|
17
|
Hypofractionated intensity-modulated radiotherapy (70 gy at 2.5 Gy per fraction) for localized prostate cancer: long-term outcomes.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.32
|
|
18
|
Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
|
Int J Radiat Oncol Biol Phys
|
2011
|
1.25
|
|
19
|
Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.24
|
|
20
|
PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.23
|
|
21
|
A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland Clinic experience.
|
J Thorac Oncol
|
2009
|
1.22
|
|
22
|
Preliminary observations on biochemical relapse-free survival rates after short-course intensity-modulated radiotherapy (70 Gy at 2.5 Gy/fraction) for localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.19
|
|
23
|
Stereotactic radiosurgery for single brainstem metastases: the cleveland clinic experience.
|
Int J Radiat Oncol Biol Phys
|
2010
|
1.14
|
|
24
|
Aggressiveness of familial prostate cancer.
|
J Clin Oncol
|
2006
|
1.13
|
|
25
|
Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
|
J Neurooncol
|
2012
|
1.07
|
|
26
|
Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study.
|
Anticancer Res
|
2003
|
1.06
|
|
27
|
Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1-3 positive lymph nodes treated with modern systemic therapy.
|
Int J Radiat Oncol Biol Phys
|
2012
|
1.06
|
|
28
|
PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.
|
Urology
|
2004
|
1.05
|
|
29
|
Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
1.04
|
|
30
|
Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2008
|
1.04
|
|
31
|
Single-fraction stereotactic body radiotherapy for spinal metastases from renal cell carcinoma.
|
J Neurosurg Spine
|
2012
|
1.03
|
|
32
|
A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer.
|
Support Care Cancer
|
2012
|
1.01
|
|
33
|
Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.00
|
|
34
|
Recursive partitioning analysis index is predictive for overall survival in patients undergoing spine stereotactic body radiation therapy for spinal metastases.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.99
|
|
35
|
PSA bounce and biochemical failure after brachytherapy for prostate cancer: a study of 820 patients with a minimum of 3 years of follow-up.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.94
|
|
36
|
Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect?
|
Cancer
|
2004
|
0.93
|
|
37
|
Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.
|
Radiat Oncol
|
2012
|
0.91
|
|
38
|
Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer.
|
Urology
|
2006
|
0.89
|
|
39
|
Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
|
Cancer J
|
2002
|
0.88
|
|
40
|
Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
|
J Neurooncol
|
2013
|
0.88
|
|
41
|
Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
|
Cancer
|
2002
|
0.87
|
|
42
|
Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
|
Lung Cancer
|
2012
|
0.87
|
|
43
|
Preoperative combined nested reverse transcriptase polymerase chain reaction for prostate-specific antigen and prostate-specific membrane antigen does not correlate with pathologic stage or biochemical failure in patients with localized prostate cancer undergoing radical prostatectomy.
|
J Clin Oncol
|
2002
|
0.87
|
|
44
|
Intraoperative radiation therapy with the photon radiosurgery system in locally advanced and recurrent rectal cancer: retrospective review of the Cleveland clinic experience.
|
Radiat Oncol
|
2012
|
0.87
|
|
45
|
Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer.
|
Prostate Cancer
|
2012
|
0.85
|
|
46
|
The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas.
|
J Neurosurg Spine
|
2010
|
0.85
|
|
47
|
Marginal recurrence requiring salvage radiotherapy after stereotactic body radiotherapy for spinal metastases.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.84
|
|
48
|
Redefining high-risk prostate cancer based on distant metastases and mortality after high-dose radiotherapy with androgen deprivation therapy.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.84
|
|
49
|
The importance of serum prostate-specific antigen testing frequency in assessing biochemical and clinical failure after prostate cancer treatment.
|
Urology
|
2009
|
0.84
|
|
50
|
External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.82
|
|
51
|
Gender, race, and survival: a study in non-small-cell lung cancer brain metastases patients utilizing the radiation therapy oncology group recursive partitioning analysis classification.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.82
|
|
52
|
Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.80
|
|
53
|
Calvarial and skull base metastases: expanding the clinical utility of Gamma Knife surgery.
|
J Neurosurg
|
2014
|
0.80
|
|
54
|
Perineural invasion on prostate needle biopsy does not predict biochemical failure following brachytherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.80
|
|
55
|
High-dose-rate endobronchial brachytherapy for recurrent airway obstruction from hyperplastic granulation tissue.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.80
|
|
56
|
Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy.
|
Urology
|
2003
|
0.79
|
|
57
|
Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.
|
Int J Radiat Oncol Biol Phys
|
2006
|
0.78
|
|
58
|
Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective.
|
Neurosurgery
|
2014
|
0.78
|
|
59
|
The Impact of Preoperative Radiation Therapy on Locoregional Recurrence in Patients with Stage IV Rectal Cancer Treated with Definitive Surgical Resection and Contemporary Chemotherapy.
|
J Gastrointest Surg
|
2015
|
0.78
|
|
60
|
Lung stereotactic body radiation therapy: regional nodal failure is not predicted by tumor size.
|
J Thorac Oncol
|
2014
|
0.77
|
|
61
|
Improved biochemical relapse-free survival for patients with large/wide glands treated with prostate seed implantation for localized adenocarcinoma of prostate.
|
Urology
|
2006
|
0.77
|
|
62
|
Brain metastases from gynecological cancers: factors that affect overall survival.
|
Technol Cancer Res Treat
|
2002
|
0.75
|
|
63
|
Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome.
|
Int J Radiat Oncol Biol Phys
|
2003
|
0.75
|
|
64
|
Editorial comment.
|
Urology
|
2012
|
0.75
|
|
65
|
Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer.
|
J Gastrointest Cancer
|
2009
|
0.75
|
|
66
|
Association of body mass index with prostate cancer biochemical failure.
|
J Urol
|
2010
|
0.75
|